Steven Cohen's ATYR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 988,677 shares of aTyr Pharma, Inc. (ATYR) worth $0, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ATYR for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q1 2025, reducing 2.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's aTyr Pharma (ATYR) Holding Value Over Time
Track share changes against reported price movement
Quarterly aTyr Pharma (ATYR) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | +4.88 M | New Buy | 4.88 M | $3.62 |
| Q1 2025 | -2.04 M | Reduce 41.76% | 2.84 M | $3.02 |
| Q2 2025 | -1.86 M | Reduce 65.24% | 988,677 | $5.07 |
| Q3 2025 | -988,677 | Sold Out | 988,677 | $0.00 |
Steven Cohen's aTyr Pharma Investment FAQs
Steven Cohen first purchased aTyr Pharma, Inc. (ATYR) in Q4 2024, acquiring 4,883,197 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held aTyr Pharma, Inc. (ATYR) for 4 quarters since Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to aTyr Pharma, Inc. (ATYR) was in Q4 2024, adding 4,883,197 shares worth $17.68 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 988,677 shares of aTyr Pharma, Inc. (ATYR), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, aTyr Pharma, Inc. (ATYR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in aTyr Pharma, Inc. (ATYR) was 4,883,197 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.